SAN FRANCISCO -
Oct. 10, 2025 -
PRLog -- The
International Conference on Innovations in Pharma R&D (InnoPharm-2025) will be held from November 3–5, 2025, at the DoubleTree by Hilton San Francisco Airport, Burlingame, CA. This premier global event will bring together leaders from the pharmaceutical industry, biotechnology, and academia to explore transformative advances shaping the future of pharmaceutical research and innovation.
Over two days, InnoPharm-2025 will showcase keynote presentations, expert sessions, and networking breaks led by distinguished speakers, including Leslie Z. Benet (University of California, San Francisco), Paul A. Insel (University of California, San Diego), and Wolfgang Sadee (Aether Therapeutics & The Ohio State University) and more. The conference will highlight emerging trends and technologies redefining the pharma landscape — from AI-driven drug discovery and precision medicine to advanced therapeutics, biologics, and novel delivery platforms.
The scientific agenda features a wide range of themes:
- Drug Discovery & Development
- Pharmacology & Pharmacokinetics
- Translational Sciences & Clinical Research
- Novel Modalities & Target Identification
- AI & ML in Pharma R&D
- Biologics, Vaccines & Nano Medicine
- Future of Drug Delivery & Therapeutics
Designed to bridge academia and industry, InnoPharm-2025 provides unparalleled opportunities for collaboration, networking, and knowledge exchange. Researchers, innovators, and young professionals are encouraged to participate and present their work, contributing to the collective advancement of global health.
All registered delegates will receive lifetime access to session recordings, networking resources, and presentation materials.
For full program details, registration, and partnership opportunities, please visit:
https://pharm-science.com/register
Account Phone Number